These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
118 related articles for article (PubMed ID: 28166258)
1. Correction: Generation and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae. Kristian SA; Ota T; Bubeck SS; Cho R; Groff BC; Kubota T; Destito G; Martin C; Laudenslager J; Koriazova L; Tahara T; Kanda Y PLoS One; 2017; 12(2):e0171732. PubMed ID: 28166258 [TBL] [Abstract][Full Text] [Related]
2. Generation and Improvement of Effector Function of a Novel Broadly Reactive and Protective Monoclonal Antibody against Pneumococcal Surface Protein A of Streptococcus pneumoniae. Kristian SA; Ota T; Bubeck SS; Cho R; Groff BC; Kubota T; Destito G; Martin C; Laudenslager J; Koriazova L; Tahara T; Kanda Y PLoS One; 2016; 11(5):e0154616. PubMed ID: 27171010 [TBL] [Abstract][Full Text] [Related]
3. Identification of the targets of cross-reactive antibodies induced by Streptococcus pneumoniae colonization. Roche AM; Weiser JN Infect Immun; 2010 May; 78(5):2231-9. PubMed ID: 20231407 [TBL] [Abstract][Full Text] [Related]
4. Correction: Genetic diversity of pneumococcal surface protein A in invasive pneumococcal isolates from Korean children, 1991-2016. Yun KW; Choi EH; Lee HJ PLoS One; 2018; 13(12):e0209511. PubMed ID: 30562396 [TBL] [Abstract][Full Text] [Related]
5. Passive protection of mice against Streptococcus pneumoniae challenge by naturally occurring and vaccine-induced human anti-PhtD antibodies. Brookes RH; Ming M; Williams K; Hopfer R; Gurunathan S; Gallichan S; Tang M; Ochs MM Hum Vaccin Immunother; 2015; 11(7):1836-9. PubMed ID: 25912273 [TBL] [Abstract][Full Text] [Related]
6. Effect of Pneumococcal Conjugate Vaccine on the Natural Antibodies and Antibody Responses Against Protein Antigens From Streptococcus pneumoniae, Haemophilus influenzae and Moraxella catarrhalis in Children With Community-acquired Pneumonia. Andrade DC; Borges IC; Adrian PV; Meinke A; Barral A; Ruuskanen O; Käyhty H; Nascimento-Carvalho CM Pediatr Infect Dis J; 2016 Jun; 35(6):683-9. PubMed ID: 26954601 [TBL] [Abstract][Full Text] [Related]
7. PppA, a surface-exposed protein of Streptococcus pneumoniae, elicits cross-reactive antibodies that reduce colonization in a murine intranasal immunization and challenge model. Green BA; Zhang Y; Masi AW; Barniak V; Wetherell M; Smith RP; Reddy MS; Zhu D Infect Immun; 2005 Feb; 73(2):981-9. PubMed ID: 15664941 [TBL] [Abstract][Full Text] [Related]
8. Protection elicited by nasal immunization with pneumococcal surface protein A (PspA) adjuvanted with bacterium-like particles against Streptococcus pneumoniae infection in mice. Li B; Chen X; Yu J; Zhang Y; Mo Z; Gu T; Kong W; Wu Y Microb Pathog; 2018 Oct; 123():115-119. PubMed ID: 29959043 [TBL] [Abstract][Full Text] [Related]
9. Relationship between surface accessibility for PpmA, PsaA, and PspA and antibody-mediated immunity to systemic infection by Streptococcus pneumoniae. Gor DO; Ding X; Briles DE; Jacobs MR; Greenspan NS Infect Immun; 2005 Mar; 73(3):1304-12. PubMed ID: 15731027 [TBL] [Abstract][Full Text] [Related]
10. Enhanced protective responses to a serotype-independent pneumococcal vaccine when combined with an inactivated influenza vaccine. Babb R; Chen A; Ogunniyi AD; Hirst TR; Kara EE; McColl SR; Alsharifi M; Paton JC Clin Sci (Lond); 2017 Jan; 131(2):169-180. PubMed ID: 27885052 [TBL] [Abstract][Full Text] [Related]
11. Distinct approaches to investigate the importance of the murine 4-1BB 4-1BBL interaction in the antibody response to Streptococcus pneumoniae. Moens L; Jeurissen A; Mittler RS; Wuyts G; Michiels G; Boon L; Ceuppens JL; Bossuyt X J Leukoc Biol; 2007 Sep; 82(3):638-44. PubMed ID: 17550973 [TBL] [Abstract][Full Text] [Related]
12. Correction: Evaluation of inactivated Bordetella pertussis as a delivery system for the immunization of mice with Pneumococcal Surface Antigen A. Castro JT; Oliveira GS; Nishigasako MA; Debrie AS; Miyaji EN; Soares-Schanoski A; Akamatsu MA; Locht C; Ho PL; Mielcarek N; Oliveira MLS PLoS One; 2020; 15(2):e0229050. PubMed ID: 32023329 [TBL] [Abstract][Full Text] [Related]
13. Antibody response to pneumolysin and to pneumococcal capsular polysaccharide in healthy individuals and Streptococcus pneumoniae infected patients. Huo Z; Spencer O; Miles J; Johnson J; Holliman R; Sheldon J; Riches P Vaccine; 2004 Mar; 22(9-10):1157-61. PubMed ID: 15003643 [TBL] [Abstract][Full Text] [Related]
14. Immunization with Pneumococcal Surface Protein K of Nonencapsulated Streptococcus pneumoniae Provides Protection in a Mouse Model of Colonization. Keller LE; Luo X; Thornton JA; Seo KS; Moon BY; Robinson DA; McDaniel LS Clin Vaccine Immunol; 2015 Nov; 22(11):1146-53. PubMed ID: 26311246 [TBL] [Abstract][Full Text] [Related]
15. PrtA immunization fails to protect against pulmonary and invasive infection by Streptococcus pneumoniae. Hsu CF; Hsiao CH; Tseng SF; Chen JR; Liao YJ; Chen SJ; Lin CS; Sytwu HK; Chuang YP Respir Res; 2018 Sep; 19(1):187. PubMed ID: 30253765 [TBL] [Abstract][Full Text] [Related]
16. Streptococcus pneumoniae heat shock protein 70 does not induce human antibody responses during infection. Kolberg J; Høiby EA; Aase A; Sletten K; Rødal G; Michaelsen TE; Bucher A FEMS Immunol Med Microbiol; 2000 Dec; 29(4):289-94. PubMed ID: 11118910 [TBL] [Abstract][Full Text] [Related]
17. Nasal vaccination with pneumococcal surface protein A in combination with cationic liposomes consisting of DOTAP and DC-chol confers antigen-mediated protective immunity against Streptococcus pneumoniae infections in mice. Tada R; Suzuki H; Takahashi S; Negishi Y; Kiyono H; Kunisawa J; Aramaki Y Int Immunopharmacol; 2018 Aug; 61():385-393. PubMed ID: 29945026 [TBL] [Abstract][Full Text] [Related]
18. Synchrony in serum antibody response to conserved proteins of Streptococcus pneumoniae in young children. Ren D; Almudevar AL; Pichichero ME Hum Vaccin Immunother; 2015; 11(2):489-97. PubMed ID: 25692218 [TBL] [Abstract][Full Text] [Related]
19. Intranasal vaccination with pneumococcal surface protein A and interleukin-12 augments antibody-mediated opsonization and protective immunity against Streptococcus pneumoniae infection. Arulanandam BP; Lynch JM; Briles DE; Hollingshead S; Metzger DW Infect Immun; 2001 Nov; 69(11):6718-24. PubMed ID: 11598043 [TBL] [Abstract][Full Text] [Related]
20. Correction: PlexinD1 Is a Novel Transcriptional Target and Effector of Notch Signaling in Cancer Cells. PLOS ONE Staff PLoS One; 2016; 11(12):e0168429. PubMed ID: 27936215 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]